Long non-coding RNA NEAT1 regulates permeability of the blood-tumor barrier via miR-181d-5p-mediated expression changes in ZO-1, occludin, and claudin-5

Van Meir, 2010, Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma, CA Cancer J. Clin., 60, 166, 10.3322/caac.20069

Neuwelt, 2008, Strategies to advance translational research into brain barriers, Lancet Neurol., 7, 84, 10.1016/S1474-4422(07)70326-5

Czupalla, 2014, In vitro models of the blood-brain barrier, Methods Mol. Biol., 1135, 415, 10.1007/978-1-4939-0320-7_34

Abbott, 2010, Structure and function of the blood-brain barrier, Neurobiol. Dis., 37, 13, 10.1016/j.nbd.2009.07.030

Gu, 2009, The molecular mechanism of dexamethasone-mediated effect on the blood-brain tumor barrier permeability in a rat brain tumor model, Neurosci. Lett., 452, 114, 10.1016/j.neulet.2008.12.047

Vorbrodt, 2003, Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view, Brain Res. Brain Res. Rev., 42, 221, 10.1016/S0165-0173(03)00177-2

Yeung, 2008, Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown, Acta Neuropathol., 115, 635, 10.1007/s00401-008-0364-4

Cai, 2015, The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144, Oncotarget, 6, 19759, 10.18632/oncotarget.4331

Miao, 2015, MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5, Cell. Signal., 27, 156, 10.1016/j.cellsig.2014.10.008

Gutschner, 2012, The hallmarks of cancer: a long non-coding RNA point of view, RNA Biol., 9, 703, 10.4161/rna.20481

Naganuma, 2013, Paraspeckle formation during the biogenesis of long non-coding RNAs, RNA Biol., 10, 456, 10.4161/rna.23547

Chakravarty, 2014, The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer, Nat. Commun., 5, 5383, 10.1038/ncomms6383

Pan, 2015, Upregulation and clinicopathological significance of long non-coding NEAT1 RNA in NSCLC tissues, Asian Pac. J. Cancer Prev., 16, 2851, 10.7314/APJCP.2015.16.7.2851

Kim, 2010, Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma, BMC Cancer, 10, 576, 10.1186/1471-2407-10-576

Li, 2015, NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer, Oncotarget, 6, 27641, 10.18632/oncotarget.4737

He, 2016, Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients, APMIS, 124, 169, 10.1111/apm.12480

He, 2004, MicroRNAs: small RNAs with a big role in gene regulation, Nat. Rev. Genet., 5, 522, 10.1038/nrg1379

Alvarez-Garcia, 2005, MicroRNA functions in animal development and human disease, Development, 132, 4653, 10.1242/dev.02073

Slaby, 2010, MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients, Neoplasma, 57, 264, 10.4149/neo_2010_03_264

Zhang, 2012, miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression, Neuro-Oncology, 14, 712, 10.1093/neuonc/nos089

Ma, 2014, MiR-181a regulates blood-tumor barrier permeability by targeting Kruppel-like factor 6, J. Cereb. Blood Flow Metab., 34, 1826, 10.1038/jcbfm.2014.152

Sun, 2012, MicroRNA-181b regulates NF-kappaB-mediated vascular inflammation, J. Clin. Invest., 122, 1973

Tominaga, 2015, Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier, Nat. Commun., 6, 6716, 10.1038/ncomms7716

Wang, 2012, MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2, J. Cancer Res. Clin. Oncol., 138, 573, 10.1007/s00432-011-1114-x

Lefebvre, 2010, The SoxD transcription factors–Sox5, Sox6, and Sox13–are key cell fate modulators, Int. J. Biochem. Cell Biol., 42, 429, 10.1016/j.biocel.2009.07.016

Hersh, 2011, SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development, Am. J. Respir. Crit. Care Med., 183, 1482, 10.1164/rccm.201010-1751OC

Ueda, 2007, Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients, Int. J. Cancer, 120, 1704, 10.1002/ijc.22472

Yang, 2013, Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice, J. Clin. Invest., 123, 418, 10.1172/JCI64547

Cesana, 2011, A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA, Cell, 147, 358, 10.1016/j.cell.2011.09.028

Xu, 2014, Long non-coding RNAs: new players in ocular neovascularization, Mol. Biol. Rep., 41, 4493, 10.1007/s11033-014-3320-5

Lopez-Pajares, 2015, A LncRNA-MAF:MAFB transcription factor network regulates epidermal differentiation, Dev. Cell, 32, 693, 10.1016/j.devcel.2015.01.028

Prensner, 2011, The emergence of lncRNAs in cancer biology, Cancer Discov., 1, 391, 10.1158/2159-8290.CD-11-0209

Clemson, 2009, An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles, Mol. Cell, 33, 717, 10.1016/j.molcel.2009.01.026

Choudhry, 2015, Tumor hypoxia induces nuclear paraspeckle formation through HIF-2alpha dependent transcriptional activation of NEAT1 leading to cancer cell survival, Oncogene, 34, 4546, 10.1038/onc.2014.431

You, 2014, MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1, Indian J. Cancer, 51, e77, 10.4103/0019-509X.154055

Zhen, 2016, Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis, Tumour Biol., 37, 673, 10.1007/s13277-015-3843-y

Cai, 2015, Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression, J. Neuropathol. Exp. Neurol., 74, 25, 10.1097/NEN.0000000000000146

Liu, 2014, Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer, Mol. Cancer, 13, 92, 10.1186/1476-4598-13-92

Jalali, 2013, Systematic transcriptome wide analysis of lncRNA-miRNA interactions, PLoS One, 8, 10.1371/journal.pone.0053823

Li, 2015, Genome-scale identification of miRNA-mRNA and miRNA-lncRNA interactions in domestic animals, Anim. Genet., 46, 716, 10.1111/age.12329

Wang, 2015, Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21, Cell. Signal., 27, 275, 10.1016/j.cellsig.2014.11.011

Zhao, 2015, miR-34c regulates the permeability of blood-tumor barrier via MAZ-mediated expression changes of ZO-1, occludin, and claudin-5, J. Cell. Physiol., 230, 716, 10.1002/jcp.24799

Zhao, 2015, MiR-34a regulates blood-tumor barrier function by targeting protein kinase Cepsilon, Mol. Biol. Cell, 26, 1786, 10.1091/mbc.e14-10-1474

Zietara, 2013, Critical role for miR-181a/b-1 in agonist selection of invariant natural killer T cells, Proc. Natl. Acad. Sci. U. S. A., 110, 7407, 10.1073/pnas.1221984110

Belkaya, 2014, Transgenic expression of microRNA-181d augments the stress-sensitivity of CD4(+)CD8(+) thymocytes, PLoS One, 9, e85274, 10.1371/journal.pone.0085274

Lefebvre, 2007, Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors, Int. J. Biochem. Cell Biol., 39, 2195, 10.1016/j.biocel.2007.05.019

Suto, 2015, Sox5 and Th17 cell differentiation, Oncotarget, 6, 19952, 10.18632/oncotarget.4784

Ma, 2009, DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer, Int. J. Cancer, 124, 2323, 10.1002/ijc.24243

Riker, 2008, The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis, BMC Med. Genet., 1, 13

Huang, 2008, Transcription factor SOX-5 enhances nasopharyngeal carcinoma progression by down-regulating SPARC gene expression, J. Pathol., 214, 445, 10.1002/path.2299

Pei, 2014, Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1, Biochem. Biophys. Res. Commun., 446, 322, 10.1016/j.bbrc.2014.02.109